ctrl K

Price Alert

Kyverna Therapeutics Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

3.40

0.10 (3.03%)

At close: Aug 20, 2025, 10:04 AM

Kyverna Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	96.62M	34.65M	37.73M	76.07M
Short-Term Investments	189.36M	22.9M	13.59M	n/a
Long-Term Investments	n/a	n/a	554K	552K
Other Long-Term Assets	3.39M	3.92M	678K	41K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.62M	3.12M	1.93M	1.02M
Total Current Assets	290.6M	60.66M	53.25M	77.09M
Property-Plant & Equipment	10.66M	10.61M	12.44M	7.81M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.04M	14.53M	13.67M	8.4M
Total Assets	304.64M	75.19M	66.92M	85.49M
Account Payables	4.62M	4.36M	1.45M	773K
Deferred Revenue	n/a	n/a	7.66M	6M
Short-Term Debt	3.94M	n/a	n/a	n/a
Other Current Liabilities	943K	9.77M	6.82M	7.2M
Total Current Liabilities	33.76M	19.86M	11.95M	15.93M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	120.68M	78K
Total Long-Term Liabilities	4.3M	6.16M	128.97M	115.81M
Total Liabilities	38.06M	26.02M	140.92M	131.74M
Total Debt	8.24M	9.08M	10.56M	5.55M
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-263.52M	-136.04M	-75.68M	-46.78M
Comprehensive Income	105K	4K	-26K	n/a
Shareholders Equity	266.59M	49.18M	-74M	-46.25M
Total Investments	189.36M	22.9M	13.59M	552K